Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$1.69 - $2.67 $20,112 - $31,775
-11,901 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$1.79 - $2.91 $3,825 - $6,218
2,137 Added 21.89%
11,901 $24,000
Q4 2020

Jan 13, 2021

BUY
$1.07 - $2.0 $10,447 - $19,528
9,764 New
9,764 $18,000

Others Institutions Holding VBLT

About Vascular Biogenics Ltd.


  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.